Showing results (2511-2520 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|March 1, 1994
Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancerP J Simons, R A Oostendorp, M P Tas, et al.Cancer Immunology, Immunotherapy : CII|March 1, 1994
Specificity and function of monoclonal antibodies directed against Ewing sarcoma cellsL R Shi, D Eichelbauer, F Borchard, et al.Cancer Immunology, Immunotherapy : CII|March 1, 1995
Effects of lethal irradiation and cyclosporin A treatment on the growth and tumoricidal activity of a T cell clone potentially useful in cancer therapyA Cesano, S Visonneau, L Cioé, et al.Cancer Immunology, Immunotherapy : CII|March 1, 1995
Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigenR K Bright, M H Shearer, R C KennedyCancer Immunology, Immunotherapy : CII|July 1, 1993
Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expressionR K Bright, M H Shearer, R C KennedyCancer Immunology, Immunotherapy : CII|August 1, 1993
A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancerH Kobayashi, H Sakahara, T Saga, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1993
The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotypeJ J Killion, R Radinsky, Z Dong, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1993
Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalencyU Srinivas, E Tagliabue, M Campiglio, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1993
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cellsA S Chong, P N Markham, H M Gebel, et al.Cancer Immunology, Immunotherapy : CII|April 10, 2002
Beta1 integrin triggering affects leukemic cell line sensitivity to natural killer cellsGonzalo Rubio, Xabier Ferez, Ana Mora, et al.Pageof 652